A detailed history of Yousif Capital Management, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Yousif Capital Management, LLC holds 28,476 shares of CORT stock, worth $1.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
28,476
Previous 29,293 2.79%
Holding current value
$1.59 Million
Previous $951,000 38.49%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$29.51 - $46.26 $24,109 - $37,794
-817 Reduced 2.79%
28,476 $1.32 Million
Q2 2024

Jul 31, 2024

SELL
$22.21 - $34.48 $88,884 - $137,988
-4,002 Reduced 12.02%
29,293 $951,000
Q1 2024

Apr 26, 2024

SELL
$21.1 - $27.46 $77,120 - $100,366
-3,655 Reduced 9.89%
33,295 $838,000
Q4 2023

Feb 01, 2024

SELL
$24.82 - $32.88 $64,035 - $84,830
-2,580 Reduced 6.53%
36,950 $1.2 Million
Q3 2023

Oct 30, 2023

SELL
$21.97 - $33.8 $70,062 - $107,788
-3,189 Reduced 7.47%
39,530 $1.08 Million
Q2 2023

Aug 02, 2023

SELL
$21.44 - $25.15 $136,358 - $159,954
-6,360 Reduced 12.96%
42,719 $950,000
Q1 2023

May 02, 2023

SELL
$19.2 - $24.47 $151,680 - $193,313
-7,900 Reduced 13.86%
49,079 $1.06 Million
Q4 2022

Jan 09, 2023

SELL
$19.95 - $29.96 $265,335 - $398,468
-13,300 Reduced 18.92%
56,979 $0
Q3 2022

Nov 04, 2022

SELL
$24.7 - $29.12 $40,261 - $47,465
-1,630 Reduced 2.27%
70,279 $1.8 Million
Q2 2022

Aug 01, 2022

SELL
$17.33 - $25.3 $146,005 - $213,152
-8,425 Reduced 10.49%
71,909 $1.71 Million
Q1 2022

May 12, 2022

SELL
$16.53 - $25.21 $32,646 - $49,789
-1,975 Reduced 2.4%
80,334 $1.81 Million
Q4 2021

Jan 31, 2022

BUY
$17.1 - $23.34 $1.41 Million - $1.92 Million
82,309 New
82,309 $1.63 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.99B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.